drugset
drugset / Trial / NCT01057433

Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin

NCT01057433 ↗

Phase 4 Completed 24 enrolled Kowa Research Institute, Inc.
Non-randomizedSingle-groupOpen-labelOther

Summary

This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.

Timeline

Start
2010-01
Primary completion
2010-12
Completion
2010-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lopinavir/ritonavir Unknown 200 mg —
Subject Lopinavir/ritonavir Unknown 800 mg —
Subject Pitavastatin Small molecule 4 mg —

Indications

No indication recorded.